These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30885958)

  • 81. Augmented gp130-mediated cytokine signalling accompanies human gastric cancer progression.
    Jackson CB; Judd LM; Menheniott TR; Kronborg I; Dow C; Yeomans ND; Boussioutas A; Robb L; Giraud AS
    J Pathol; 2007 Oct; 213(2):140-51. PubMed ID: 17724739
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Inhibition of β-catenin signaling suppresses pancreatic tumor growth by disrupting nuclear β-catenin/TCF-1 complex: critical role of STAT-3.
    Pramanik KC; Fofaria NM; Gupta P; Ranjan A; Kim SH; Srivastava SK
    Oncotarget; 2015 May; 6(13):11561-74. PubMed ID: 25869100
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Bazedoxifene: a third-generation selective estrogen receptor modulator for treatment of postmenopausal osteoporosis.
    Stump AL; Kelley KW; Wensel TM
    Ann Pharmacother; 2007 May; 41(5):833-9. PubMed ID: 17426077
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis.
    Fischer P; Hilfiker-Kleiner D
    Basic Res Cardiol; 2007 Jul; 102(4):279-97. PubMed ID: 17530315
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Study of Fibronectin Type III-Like Domains Role in Activation of gp130 Receptor.
    Stepanov AV; Rybinets AS; Dronina MA; Deev SM
    Bull Exp Biol Med; 2016 May; 161(1):72-4. PubMed ID: 27270939
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Repurposing of drugs as STAT3 inhibitors for cancer therapy.
    Thilakasiri PS; Dmello RS; Nero TL; Parker MW; Ernst M; Chand AL
    Semin Cancer Biol; 2021 Jan; 68():31-46. PubMed ID: 31711994
    [TBL] [Abstract][Full Text] [Related]  

  • 87. PMA treated THP-1-derived-IL-6 promotes EMT of SW48 through STAT3/ERK-dependent activation of Wnt/β-catenin signaling pathway.
    Gao S; Hu J; Wu X; Liang Z
    Biomed Pharmacother; 2018 Dec; 108():618-624. PubMed ID: 30243096
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Nonspecific Inhibition of IL6 Family Cytokine Signalling by Soluble gp130.
    Widjaja AA; Cook SA
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338642
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor β Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation.
    Miguchi M; Hinoi T; Shimomura M; Adachi T; Saito Y; Niitsu H; Kochi M; Sada H; Sotomaru Y; Ikenoue T; Shigeyasu K; Tanakaya K; Kitadai Y; Sentani K; Oue N; Yasui W; Ohdan H
    PLoS One; 2016; 11(11):e0166422. PubMed ID: 27835699
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Raloxifene and antiestrogenic gonadorelin inhibits intestinal tumorigenesis by modulating immune cells and decreasing stem-like cells.
    Janakiram NB; Mohammed A; Brewer M; Bryant T; Biddick L; Lightfoot S; Pathuri G; Gali H; Rao CV
    Cancer Prev Res (Phila); 2014 Mar; 7(3):300-9. PubMed ID: 24431404
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The dynamics of signal triggering in a gp130-receptor complex.
    Matadeen R; Hon WC; Heath JK; Jones EY; Fuller S
    Structure; 2007 Apr; 15(4):441-8. PubMed ID: 17437716
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The RhoU/Wrch1 Rho GTPase gene is a common transcriptional target of both the gp130/STAT3 and Wnt-1 pathways.
    Schiavone D; Dewilde S; Vallania F; Turkson J; Di Cunto F; Poli V
    Biochem J; 2009 Jun; 421(2):283-92. PubMed ID: 19397496
    [TBL] [Abstract][Full Text] [Related]  

  • 93. A comprehensive review on anticancer mechanism of bazedoxifene.
    Zafar E; Maqbool MF; Iqbal A; Maryam A; Shakir HA; Irfan M; Khan M; Li Y; Ma T
    Biotechnol Appl Biochem; 2022 Apr; 69(2):767-782. PubMed ID: 33759222
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Mouse models of gastrointestinal tumors.
    Taketo MM
    Cancer Sci; 2006 May; 97(5):355-61. PubMed ID: 16630131
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Critical Conditions for Studying Interleukin-11 Signaling In Vitro and Avoiding Experimental Artefacts.
    Viswanathan S; Ng B; Widjaja AA; Pua CJ; Tham N; Tan J; Cook SA; Schafer S
    Curr Protoc; 2021 Sep; 1(9):e251. PubMed ID: 34570432
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Bazedoxifene inhibits sustained STAT3 activation and increases survival in GBM.
    Wightman SM; Alban TJ; Chen X; Lathia JD; Wang Y; Stark GR
    Transl Oncol; 2021 Nov; 14(11):101192. PubMed ID: 34365219
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Identification of Serum Biomarkers to Monitor Therapeutic Response in Intestinal-Type Gastric Cancer.
    Dagley LF; Yousef J; Preaudet A; Loving A; Webb AI; Ernst M; Putoczki TL
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542101
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Expression analysis of proline rich 15 (Prr15) in mouse and human gastrointestinal tumors.
    Meunier D; Patra K; Smits R; Hägebarth A; Lüttges A; Jaussi R; Wieduwilt MJ; Quintanilla-Fend L; Himmelbauer H; Fodde R; Fundele RH
    Mol Carcinog; 2011 Jan; 50(1):8-15. PubMed ID: 21061267
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Defective glycosylation leads to defective gp130-dependent STAT3 signaling in PGM3-deficient patients.
    Ben-Ali M; Ben-Khemis L; Mekki N; Yaakoubi R; Ouni R; Benabdessalem C; Ben-Mustapha I; Barbouche MR
    J Allergy Clin Immunol; 2019 Apr; 143(4):1638-1640.e2. PubMed ID: 30578875
    [No Abstract]   [Full Text] [Related]  

  • 100. What lurks beneath: IL-11, via Stat3, promotes inflammation-associated gastric tumorigenesis.
    Merchant JL
    J Clin Invest; 2008 May; 118(5):1628-31. PubMed ID: 18431518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.